Premium research materials.
Research materials only • Not for human consumption
$49.99
A melanocortin receptor agonist studied in neuroendocrine and behavioural research models.
From the literature
Journal of Sexual Medicine · 2019
Two randomised phase 3 trials reported improvement in desire and reduced distress scores relative to placebo, with transient nausea and flushing the most common effects.
Nature Reviews Endocrinology · 2018
A review of MC3R and MC4R signalling in the hypothalamus, describing how central rather than vascular mechanisms distinguish melanocortin agonists from PDE5 inhibitors.
Summaries of published literature, provided for context only. Nothing here is medical advice, and this product is sold for laboratory research use only.
Pairs well with
Triple-agonist research compound.
Dual-agonist metabolic research.
Long-acting amylin analogue.
Body protection compound.
PT-141
$49.99
